Fibrin Fibrinogen Degradation Products
-
Subject Areas on Research
-
A Novel Analytic Technique to Measure Associations Between Circulating Biomarkers and Physical Performance Across the Adult Life Span.
-
Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers).
-
Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons.
-
Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
-
An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy.
-
Association of interleukin-6 and other biologic variables with depression in older people living in the community.
-
Association of sleep onset of acute coronary syndrome with sleep apnea syndrome and abnormal diurnal variation of hemostasis and adipokine levels.
-
Biomarkers in atrial fibrillation: a clinical review.
-
COVID-19 and its implications for thrombosis and anticoagulation.
-
Cardiac marker testing: where should we focus?
-
Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products.
-
Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
-
Characterization of the hypercoagulable state in patients with sickle cell disease.
-
Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma.
-
Clinical implications of systemic inflammatory response syndrome following thoracic aortic stent-graft placement.
-
Clinical probability and D-dimer testing: how should we use them in clinical practice?
-
Coagulation abnormalities and thrombosis in patients with COVID-19.
-
Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly.
-
Coagulopathy in COVID-19.
-
Coagulopathy in α-galactosyl transferase knockout pulmonary xenotransplants.
-
Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.
-
Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
-
Complications of low-dose heparin prophylaxis in gynecologic oncology surgery.
-
Concentrated ambient ultrafine particle exposure induces cardiac changes in young healthy volunteers.
-
Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons.
-
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
-
D-Dimer elevation and adverse outcomes.
-
D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.
-
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.
-
D-dimer antigen: current concepts and future prospects.
-
D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease.
-
D-dimer for the diagnosis of venous thromboembolism in children.
-
D-dimer levels in VTE patients with distal and proximal clots.
-
D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism.
-
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial.
-
Diagnosis of lower limb deep venous thrombosis in emergency department patients: performance of Hamilton and modified Wells scores.
-
Discriminative capacity of biomarkers for acute stroke in the emergency department.
-
Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures.
-
Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation.
-
Does an immunochromatographic D-dimer exclude acute lower limb deep venous thrombosis?
-
Does this patient have pulmonary embolism?
-
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
-
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
-
Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study.
-
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
-
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
-
HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors.
-
Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease.
-
Importance of pretest probability score and D-dimer assay before sonography for lower limb deep venous thrombosis.
-
Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis.
-
Insignificant blood damage in calves with a total artificial heart up to six months.
-
International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs.
-
Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
-
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.
-
Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy.
-
Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
-
Multicenter Evaluation of the YEARS Criteria in Emergency Department Patients Evaluated for Pulmonary Embolism.
-
Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery.
-
Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.
-
Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
-
Plasma thrombospondin as an indicator of intravascular platelet activation in patients with vasculitis.
-
Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3.
-
Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation.
-
Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation.
-
Pulmonary embolism: accuracy and safety of a negative CT pulmonary angiogram and value of a negative D-dimer assay to exclude CT pulmonary angiogram-detectable pulmonary embolism.
-
Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease.
-
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial.
-
Relations of a marker of endothelial activation (s-VCAM) to function and mortality in community-dwelling older adults.
-
Reply to the authors of "Age-adjusted D-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients".
-
SARS-CoV-2 and Stroke in a New York Healthcare System.
-
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
-
Sex-related differences in D-dimer levels for venous thromboembolism screening.
-
The clearance of human fibrinogen fragments D1, D2, D3 and fibrin fragment D1 dimer in mice.
-
The clearance of human fibrinogen fragments X and Y in mice: a process mediated by the fragment D receptor.
-
The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
-
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.
-
The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen.
-
The influence of various patient characteristics on D-dimer concentration in critically ill patients and its role as a prognostic indicator in the intensive care unit setting.
-
The macrophage-mediated regulation of hepatocyte synthesis of antithrombin III and alpha 1-proteinase inhibitor.
-
The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.
-
The role of ligand-ligand interactions in competition by fibrinogen and fibrin degradation products for fibrinogen binding to human platelets.
-
The role of the porcine von Willebrand factor: baboon platelet interactions in pulmonary xenotransplantation.
-
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
-
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial.
-
Tumor necrosis factor, natural killer activity and other measures of immune function and inflammation in elderly men with heart failure.
-
Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects.
-
Venous thromboembolic disease: where does multidetector computed tomography fit?
-
Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism.
-
Keywords of People